SOLID TUMOR
Clinical trials for SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMOR trials appear
Sign up with your email to follow new studies for SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hard-to-treat breast cancer: drug targets hidden genetic switch
Disease control Not yet recruitingThis study tests the drug olaparib in 30 women with advanced triple-negative breast cancer that has come back or spread. Unlike other studies, these patients do not have the usual BRCA gene mutations but have a different change (BRCA1 promoter methylation) that may make the cance…
Matched conditions: SOLID TUMOR
Phase: PHASE2 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New drug atamparib targets tough lung cancers in early trial
Disease control Not yet recruitingThis study tests an experimental drug, atamparib, in about 178 adults with advanced non-small cell lung cancer that has spread or cannot be removed. Participants must have tried at least one prior treatment and have a KRAS gene mutation. The goal is to find the safest dose and se…
Matched conditions: SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Nerviano Medical Sciences (Shanghai) Ltd. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New combo aims to revive failed cancer immunotherapy
Disease control Not yet recruitingThis early-phase study tests whether adding the drug 5-Azacitidine to standard immunotherapy can help patients whose solid tumors no longer respond to PD-1/PD-L1 inhibitors. About 35 adults with advanced or metastatic tumors will receive the combination to find the safest dose an…
Matched conditions: SOLID TUMOR
Phase: PHASE1 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New mRNA vaccine combo targets Hard-to-Treat cancers
Disease control Not yet recruitingThis study tests a new mRNA vaccine designed to help the immune system recognize and attack cancer cells. It is given together with an immunotherapy drug (anti-PD-1) to people with advanced solid tumors that have spread or cannot be removed. The goal is to see if the combination …
Matched conditions: SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Engineered immune cells take aim at Hard-to-Treat KRAS cancers
Disease control Not yet recruitingThis early-phase study tests a new treatment called TCR-T, where a patient's own immune cells are modified in a lab to better recognize and attack cancer cells driven by KRAS mutations. The trial will enroll 25 adults with advanced solid tumors (such as colorectal or lung cancer)…
Matched conditions: SOLID TUMOR
Phase: EARLY_PHASE1 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Not yet recruitingThis study tests an experimental drug called BSI-082 in people with advanced or metastatic solid tumors that have stopped responding to standard treatments. In the first part, participants receive BSI-082 alone at increasing doses. In the second part, they receive BSI-082 combine…
Matched conditions: SOLID TUMOR
Phase: PHASE1 • Sponsor: Lei Zheng • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
New study aims to extend First-Line cancer treatment success with targeted tumor ablation
Disease control Not yet recruitingThis study tests whether destroying remaining tumors with local therapy after initial chemotherapy or targeted therapy can extend the time before cancer grows again. It includes adults with various solid tumors whose disease hasn't worsened after three months of standard first-li…
Matched conditions: SOLID TUMOR
Sponsor: Chirec • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
Taste-Bud rescue: miracle fruit trial for cancer patients
Symptom relief Not yet recruitingThis study tests whether freeze-dried miracle fruit (MiraBurst) can help improve taste changes caused by cancer treatment in adults with solid tumors. Participants will take one mini-square up to four times a day before meals for 90 days. The goal is to see if it makes food taste…
Matched conditions: SOLID TUMOR
Phase: NA • Sponsor: Case Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 22, 2026 13:52 UTC
-
Massive biobank aims to unlock secrets of hereditary tumors
Knowledge-focused Not yet recruitingThis study will collect tumor samples and health information from up to 50,000 adults with hereditary cancers. Researchers will use these samples to create lab models of the tumors, which can help them understand how these cancers grow and test new treatments. The goal is to spee…
Matched conditions: SOLID TUMOR
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 26, 2026 04:00 UTC